(Q37634983)

English

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma

scientific article published on 27 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma (English)

1 reference

Europe PubMed Central

21 August 2017

1 reference

based on heuristic

inferred from title

Nadeem R. Abu-Rustum

2

object named as

Nadeem R Abu-Rustum

1 reference

Europe PubMed Central

21 August 2017

6

object named as

Alexia Iasonos

1 reference

Europe PubMed Central

21 August 2017

1

object named as

Vicky Makker

1 reference

Europe PubMed Central

21 August 2017

Carol Aghajanian

4

object named as

Carol A Aghajanian

1 reference

Europe PubMed Central

21 August 2017

author name string

Kaled M Alektiar

3

1 reference

Europe PubMed Central

21 August 2017

Qin Zhou

5

1 reference

Europe PubMed Central

21 August 2017

Martee L Hensley

7

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

27 August 2008

1 reference

Europe PubMed Central

21 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

21 August 2017

111

1 reference

Europe PubMed Central

21 August 2017

249-254

1 reference

Europe PubMed Central

21 August 2017

2

1 reference

Europe PubMed Central

21 August 2017

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

23 August 2017

The management of patients with uterine sarcoma: a debated clinical challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

23 August 2017

Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

23 August 2017

Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

23 August 2017

Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

23 August 2017

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

23 August 2017

Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

6 September 2017

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952566

1 September 2018

The role of radiation therapy in the management of uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.035

7 January 2021

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.035

7 January 2021

Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.035

7 January 2021

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18755503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18755503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YGYNO.2008.06.035

1 reference

Europe PubMed Central

21 August 2017

release_lzpj27z65reqziyfionkxfhvja

1 reference

https://api.fatcat.wiki/v0/release/lzpj27z65reqziyfionkxfhvja

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37634983&oldid=2089639017"